Literature DB >> 15825965

Race-ethnic differences in the extent, prevalence, and progression of coronary calcium.

Miwa Kawakubo1, Laurie LaBree, Min Xiang, Terence M Doherty, Nathan D Wong, Stanley Azen, Robert Detrano.   

Abstract

OBJECTIVE: To compare across four race-ethnic groups the baseline prevalence and extent of coronary calcium and the 7-year rate of progression in the extent of coronary calcium.
DESIGN: The South Bay Heart Watch is a prospective cohort study designed to appraise the value of coronary calcium for predicting cardiovascular outcomes in asymptomatic adults with cardiac risk factors. Statistical analyses were conducted to evaluate ethnic differences in the prevalence, extent, and progression of coronary calcium among Caucasian, African-American, Hispanic, and Asian participants.
SETTING: Population-based study. PATIENTS OR PARTICIPANTS: Between December 1990 and December 1992, 1289 participants without coronary heart disease underwent baseline risk factor screening and computed tomography for coronary calcification (Cohort 1). Seven years later, 828 (64%) participants returned for follow-up evaluation and re-scanning (Cohort 2). MAIN OUTCOME MEASURES: Prevalence, extent, and progression of coronary artery calcium.
RESULTS: In Cohort 2, compared to Whites, African Americans had a lower prevalence of coronary calcium at baseline (P=.012) and follow-up (P=.005), smaller calcium scores at baseline (P=.005) and follow-up (P=.0004), and less progression (P=.001); Hispanics had a lower prevalence of coronary calcium at follow-up (P=.04) with smaller calcium scores (P=.011), and less progression (P=.009). In contrast, no differences were seen between Whites and Asian/Pacific Islanders. Race-ethnic differences in progression persisted after adjusting for risk factors and participation bias (P<.05).
CONCLUSIONS: The present results lend further credence to the notion that race-ethnic differences exist in the prevalence and rate of progression of coronary calcification. The relationship between calcification and the incidence of coronary heart disease in these race-ethnic groups needs further exploration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15825965

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  12 in total

1.  Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging.

Authors:  Matthijs Oudkerk; Arthur E Stillman; Sandra S Halliburton; Willi A Kalender; Stefan Möhlenkamp; Cynthia H McCollough; Rozemarijn Vliegenthart; Leslee J Shaw; William Stanford; Allen J Taylor; Peter M A van Ooijen; Lewis Wexler; Paolo Raggi
Journal:  Eur Radiol       Date:  2008-07-24       Impact factor: 5.315

2.  Bone Mineral Density and Progression of Subclinical Atherosclerosis in African-Americans With Type 2 Diabetes.

Authors:  Lynne E Wagenknecht; Jasmin Divers; Thomas C Register; Gregory B Russell; Donald W Bowden; Jianzhao Xu; Carl D Langefeld; Leon Lenchik; Keith A Hruska; J Jeffrey Carr; Barry I Freedman
Journal:  J Clin Endocrinol Metab       Date:  2016-08-23       Impact factor: 5.958

3.  Evolving approaches to the management of heart failure with preserved ejection fraction in patients with coronary artery disease.

Authors:  Sanjiv J Shah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-01

4.  Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus.

Authors:  Elisa Y Rhew; Susan M Manzi; Alan R Dyer; Amy H Kao; Natalya Danchenko; Emma Barinas-Mitchell; Kim Sutton-Tyrrell; David D McPherson; William Pearce; Daniel Edmundowicz; George T Kondos; Rosalind Ramsey-Goldman
Journal:  Transl Res       Date:  2008-12-09       Impact factor: 7.012

Review 5.  Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging.

Authors:  Matthijs Oudkerk; Arthur E Stillman; Sandra S Halliburton; Willi A Kalender; Stefan Möhlenkamp; Cynthia H McCollough; Rozemarijn Vliegenthart; Leslee J Shaw; William Stanford; Allen J Taylor; Peter M A van Ooijen; Lewis Wexler; Paolo Raggi
Journal:  Int J Cardiovasc Imaging       Date:  2008-05-27       Impact factor: 2.357

6.  Comparison of subclinical coronary atherosclerosis and risk factors in unselected populations in Germany and US-America.

Authors:  Axel Schmermund; Nils Lehmann; Lawrence F Bielak; PanFong Yu; Patrick F Sheedy; Andrea E Cassidy-Bushrow; Stephen T Turner; Susanne Moebus; Stefan Möhlenkamp; Andreas Stang; Klaus Mann; Karl-Heinz Jöckel; Raimund Erbel; Patricia A Peyser
Journal:  Atherosclerosis       Date:  2007-05-29       Impact factor: 5.162

7.  Matrix gla protein gene polymorphism is associated with increased coronary artery calcification progression.

Authors:  Andrea E Cassidy-Bushrow; Lawrence F Bielak; Albert M Levin; Patrick F Sheedy; Stephen T Turner; Eric Boerwinkle; Xihong Lin; Sharon L R Kardia; Patricia A Peyser
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-10       Impact factor: 8.311

8.  Genetic ancestry is associated with subclinical cardiovascular disease in African-Americans and Hispanics from the multi-ethnic study of atherosclerosis.

Authors:  Christina L Wassel; James S Pankow; Carmen A Peralta; Shweta Choudhry; Michael F Seldin; Donna K Arnett
Journal:  Circ Cardiovasc Genet       Date:  2009-09-19

9.  Racial differences in the prevalence of severe aortic stenosis.

Authors:  Devin K Patel; Kelly D Green; Marat Fudim; Frank E Harrell; Thomas J Wang; Mark A Robbins
Journal:  J Am Heart Assoc       Date:  2014-05-28       Impact factor: 5.501

10.  Genetics of coronary artery calcification among African Americans, a meta-analysis.

Authors:  Mary K Wojczynski; Mingyao Li; Lawrence F Bielak; Kathleen F Kerr; Alex P Reiner; Nathan D Wong; Lisa R Yanek; Liming Qu; Charles C White; Leslie A Lange; Jane F Ferguson; Jing He; Taylor Young; Thomas H Mosley; Jennifer A Smith; Brian G Kral; Xiuqing Guo; Quenna Wong; Santhi K Ganesh; Susan R Heckbert; Michael E Griswold; Daniel H O'Leary; Matthew Budoff; J Jeffrey Carr; Herman A Taylor; David A Bluemke; Serkalem Demissie; Shih-Jen Hwang; Dina N Paltoo; Joseph F Polak; Bruce M Psaty; Diane M Becker; Michael A Province; Wendy S Post; Christopher J O'Donnell; James G Wilson; Tamara B Harris; Maryam Kavousi; L Adrienne Cupples; Jerome I Rotter; Myriam Fornage; Lewis C Becker; Patricia A Peyser; Ingrid B Borecki; Muredach P Reilly
Journal:  BMC Med Genet       Date:  2013-07-19       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.